← 返回

Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.

Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.

期刊: Clinical and experimental pharmacology & physiology 日期: 2026-09-01 PMID: 42642864 DOI: 10.1111/1440-1681.70154 浏览: 9
作者: Liu J, Yamashita K, Yamano S
J, L., K, Y., & S, Y. (2026). Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.. Clinical and experimental pharmacology & physiology. https://doi.org/10.1111/1440-1681.70154
J L, K Y, S Y. Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.. Clinical and experimental pharmacology & physiology. 2026; doi: 10.1111/1440-1681.70154
J L, K Y, S Y. Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.[J]. Clinical and experimental pharmacology & physiology. 2026. DOI: 10.1111/1440-1681.70154.
@article{j2026,
  author = {Liu J and Yamashita K and Yamano S},
  title = {Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.},
  journal = {Clinical and experimental pharmacology & physiology},
  year = {2026},
  doi = {10.1111/1440-1681.70154},
  note = {PMID: 42642864},
}
TY  - JOUR
AU  - Liu J
AU  - Yamashita K
AU  - Yamano S
TI  - Early Cardiotoxic Remodelling Precedes Hepatic Fibrosis and Increases Susceptibility to Lethal Arrhythmias in Wild-Type MASH Mice.
T2  - Clinical and experimental pharmacology & physiology
PY  - 2026
DO  - 10.1111/1440-1681.70154
AN  - PMID:42642864
ER  - 

摘要

OBJECTIVE: Metabolic dysfunction-associated steatohepatitis (MASH) is increasingly linked to cardiovascular complications; however, the mechanisms underlying the association between hepatic injury and cardiotoxicity remain unclear. This study aimed to establish a wild-type mouse model of MASH with cardiac involvement and to characterise the temporal relationship between hepatic and cardiac alterations during disease progression. METHODS: Male C57BL/6J mice were fed a standard diet or a low-carbohydrate, high-protein, high-cholesterol (LCHP-HC) diet with or without non-excessive ethanol for 12 or 24 weeks. Arrhythmogenic susceptibility was assessed using provocation testing. Hepatic and cardiac alterations were evaluated by histology, immunofluorescence, and quantitative RT-PCR. RESULTS: The LCHP-HC diet combined with ethanol induced histological MASH and markedly increased susceptibility to lethal arrhythmias. At 12 weeks, cardiac remodelling characterised by inflammation, mild fibrosis, and connexin-43 dysregulation was evident in the absence of hepatic fibrosis, indicating early cardiotoxic remodelling. At 24 weeks, hepatic fibrosis and hepatic sympathetic activation became evident, whereas local cardiac sympathetic activation remained unchanged, indicating a temporal dissociation in which cardiac remodelling preceded hepatic fibrotic progression. CONCLUSION: Early cardiotoxic remodelling preceded hepatic fibrosis and was associated with increased arrhythmogenic susceptibility during MASH progression. These findings demonstrate that cardiac remodelling develops early in experimental MASH and reveal a stage-dependent temporal association between hepatic disease progression and cardiac vulnerability.

AI 智能解读

相关文献

返回分类: 心律失常 查看原文 (DOI)
已选择 0 篇文献